Therapeutic Pipeline Program

The Therapeutic Pipeline Program funds novel approaches and interventions as well as repurposed or repositioned therapies approved or clinically safe from other disease indications. Pharmacological and non-pharmacological therapies are encouraged to apply.

Program Priorities:

• Assay development, early screening campaigns, hit-to-lead and lead optimization
• Proof-of-concept
• Pharmacokinetics, pharmacodynamics and safety

Funding: $500,000 total 

Duration: 2 years

Research Authority due date: 14.9.21

LOI (required) due date: 28.9.21

Full proposal due date: 13.1.22